SKI Market

Indian Indices

Sensex

82,814.71 316.57
( 0.38%)

Global Indices

Nasdaq

49,410.74 -272.93
(-0.55%)

Dow Jones

6,881.90 -20.41
(-0.30%)

Hang Seng

56,838.27 -629.56
(-1.10%)

Nikkei 225

10,691.66 64.62
(0.61%)

Forex

USD-INR

90.70 0.01
(0.01%)

EUR-INR

107.23 -0.14
(-0.13%)

GBP-INR

122.83 -0.27
(-0.22%)

JPY-INR

0.59 0.00
(-0.51%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Shukra Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524632

INE551C01044

1.5028279

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

58.81

1725.24

EPS(TTM)

Face Value()

Div & Yield %

0.67

0.03

Back

KIC Metaliks standalone net profit declines 50.00% in the September 2025 quarter

Nov 16,2025

Net profit of KIC Metaliks declined 50.00% to Rs 0.08 crore in the quarter ended September 2025 as against Rs 0.16 crore during the previous quarter ended September 2024. Sales declined 22.10% to Rs 182.42 crore in the quarter ended September 2025 as against Rs 234.18 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	182.42	234.18	-22
OPM %	3.82	2.72	-
PBDT	3.88	3.84	1
PBT	0.15	0.12	25
NP	0.08	0.16	-50

82,814.71 316.57 ( 0.38%)

49,410.74 -272.93 (-0.55%)

6,881.90 -20.41 (-0.30%)

56,838.27 -629.56 (-1.10%)

10,691.66 64.62 (0.61%)

90.70 0.01 (0.01%)

107.23 -0.14 (-0.13%)

122.83 -0.27 (-0.22%)

0.59 0.00 (-0.51%)